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Summary: Epitestosterone, a Ci9-steroid with anti-androgenic activity, was determined in the plasma of 234 boys
and men from the ages of 6-86 years, and in the prostate tissue of 15 men 55-82 years of age. It was documented
that, while in adulthood the concentration of epitestosterone is about ten times lower than the concentration of
testosterone, in the pre-pubertal period the level of epitestosterone is similar or even higher than that of testosterone.
In the hyperplastic prostate tissue the content of epitestosterone is comparable to that of androstenedione, it is about
twice as high as the content of testosterone and approximately half that of the content of dihydrotestosterone. At
least in the case of pre-pubertal boys and in the prostatic tissue it is therefore possible to include epitestosterone
into consideration as a regulatory factor for the androgen-dependent events.
Introduction
Epitestosterone, a 17a-epimer of testosterone, was dis-
covered as a mammalian endogenous steroid by Clark &
Kochakian in 1947 (1), and for 40 years it was consid-
ered as a biologically totally inactive compound (2).
Certain attention was paid to it as an internal standard
in steroid analysis used for the control of testosterone
abuse by athletes, and the methodology, based on deter-
mining the ratio of testosterone to epitestosterone (3) in
the urine, was recognized by the International Olympic
Committee in 1987 as the criterion for proving the abuse
of testosterone in sports.
In 1987 a short report appeared in dermatological litera-
ture on the effect of epitestosterone on the side organ of
a golden hamster, in which this steroid inhibited the ef-
fect of testosterone on the skin adnexa. Epitestosterone
was designated as an anti-androgen, even though the
mechanism of this effect was not studied (4).
In our institute, and also in some other laboratories,
some of the physiological effects of epitestosterone were
therefore studied to elucidate the mechanism of its ef-
fect, as is summarized is table 1.
These findings led us to seek the answer to the question
as to whether epitestosterone is present in the circulation
and tissues of humans in such a concentration to allow
its anti-androgenic effects to play some role in hormonal
homeostasis. While sufficient facts have been assembled
in the literature on the urinary excretion of epitestoster-
one (5, 25, 26), data on its concentration in human blood
were rare (5) and so far there are none at all on its tissue
concentration. Therefore we attempted
1) to ascertain the concentrations of epitestosterone in
the blood of boys and men of various age groups, and
2) to find out to what extent the concentration of epites-
tosterone in the tissue of the hyperplastic prostate can
compete with the concentrations of androgens in this
secondary sexual gland.
Tab. 1 Some reported effects of epitestosterone
In vivo and in vitro effects Animal Reference
rat, mouse (6)
rat (6)
rat (6, 19)
rat, human (7, 8)
l ) The study was supported by grant No. 1432-3 of the Internal
Grant Agenture of the Ministry of Health of the Czech Republic.
Inhibition of sebaceous glands hamster (4)
Inhibition of hair follicle hamster (4)
development
Reduction in the weight of
androgen-dependent organs
Competitive binding on the
androgen receptors
Inhibition of steroid 5a-reductase
Inhibition of 17a-hydroxylase and
17,20-lyase
Antirenotropic effect mouse (20)
Inhibition of 11 ß-hydroxysteroid rat (9)
dehydrogenase
Inhibition of spermatogenesis rat (11)
Modulation of secretion and rat (10, 21)
production of lutropin and
follitropin
Inhibition of bone mineralization mouse (22)
Effect on experimental carcinoma human, rat (23)
of the prostate
Non-genomic effect on relaxation rat (24)
of the uterine muscle
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Prostate tissue, 1g
Aliquot for protein determination W Homogenate, 1 ml
3 χ (analyses In triplicate) X
Dry residue in methanol
Equivalent of 0.058 g tissue
Homogenization in 5 ml distilled water
Extraction
1) 5 ml diethylether, freezing
2)petroleum ether (b.p. 60-80 °C)
- methanol - water (5+4+1)
HPLC column..SGX C-18, δμτη, 250x4 mm, TESSEK; mp..methanol-water (7+3);
column temp..50 °C; flow rate..0.5 ml/min
Androstenedione
RT=11.67 min
Testosterone
RT=13min
Epitestosterone
RT=14.5 min
Dihydrotestosterone
RT=17.33 min
Scheme 1 Flow-chart of the method for the determination of epitestosterone and
other Gig-steroids by HPLC and radioimmunoassay.
b. p. = boiling point; RT = retention time
Materials and Methods
Healthy subjects, patients and blood and
tissue sampling
In order to determine the normal concentration of epitestosterone,
blood was taken from 156 healthy individuals in the age group
6—65 years, who had been invited by random selection for a sur-
vey of iodine deficiency in the district of Usti, as a part of another
research project (12).
We completed the group of elderly men with 78 otherwise
healthy men of up to 86 years of age, who had been invited at
random into the general practitioner consulting room for pros-
tate-specific antigen screening in another study. The blood was
withdrawn from the cubital vein between 8—10 in the morning
into heparin coated vials. Not more than 2 h later plasma was
separated and stored in a freezer at — 20 °C until processed in
the laboratory.
The tissue samples of the hyperplastic prostates were obtained from
15 patients who had been operated on in the period October—De-
cember 1993 for adenoma of the prostate with transabdominal su-
prapubic entry at the Urological Clinic of the 1st Medical Faculty
of the Charles University in Prague. The patients were between the
ages of 55—82 years, the average weight of the dissected gland
was 60.5 g. The criteria for exclusion from the group were a former
or contemporary medical therapy of hyperplasia of the prostate,
hormonal treatment of any type for three months before the opera-
tion and defects of the liver metabolism. The tissue removed surgi-
cally was examined histologically by a pathologist and stored in a
freezer at -20 °C. For details see 1. c. (13).
Determination of steroids
The tissue steroids were extracted and cleaned according to
Scheme 1 by liquid chromatography under the conditions given in
detail elsewhere (13), the plasmatic steroids were determined with-
out Chromatographie purification, the plasma epitestosterone was
determined by the extraction technique according to Bilek (5). The
epitestosterone was determined by the original radioimmunological
method (5), testosterone, androstenedione and dihydrotestosterone
were determined by conventional radioimmunoassay (14—16). For
the method of steroid determination in prostatic tissue the recovery
was checked by spiking with 500 pg of each steroid per g of tissue.
The recovery was 88.2%, 89.1%, 93.0%, and 115%, respectively
for androstenedione, testosterone, epitestosterone and dihydrotes-
tosterone.
Statistical analysis
The values are given as arithmetical average ± SEM and median
± standard deviation of median. The t-test for different group vari-
ances was used for inter-group comparison. Partly the linearized
regression was carried out by the method of weighted least squares,
partly the stepwise polynomial regression for constants of polyno-
mials lying on the level of probability p < 0.05 was performed.
The statistical significance of the correlation coefficients was deter-
mined by the F test.
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Fig. 1 Plasma concentration of testosterone, epitestosterone, and
dihydrotestosterone in boys and men depending on age (in paren-
theses: n).
grey bar: testosterone; black bar: epitestosterone; light grey bar:
dihydrotestosterone mean + 2 S. D.
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Fig. 2 Age-dependence of plasma concentration of epitestosterone.
a) average values + S. E. M., b) median + S. E. of median.
Results
The normal concentration of epitestosterone in
the blood of males and its dependence on age
The average concentration of epitestosterone, dihy-
drotestosterone and testosterone in the plasma of boys
and men in various age groups from 6 to 65 years is
given in figure 1. In the case of all the observed Ci9-
steroids there is a remarkable rise in the level in the
course of puberty, and the highest average concentration
is in the age group of 26—35 years, with the exception
of epitestosterone, which maintains a practically con-
stant level in all age groups after attaining adulthood.
The lower concentration in the age group of men of 26—
35 years may be due to the limited size of this age cate-
gory. The increasing trend in puberty is most striking in
testosterone, and least marked in epitestosterone. The
course of age dependence of the average levels of epites-
tosterone is given in figure 2a, the median in figure 2b.
The significance of the differences between the various
age groups for epitestosterone is shown in table 2. The
course of the ratios of concentration of epitestosterone
to the concentration of testosterone depending on age is
given in figure 3.
The level of epitestosterone correlates positively with
testosterone and with dihydrotestosterone (r = 0.586,
p < 0.001, resp. r = 0.417, p < 0.001) and the ratio
epitestosterone: testosterone correlates with age accord-
ing to the equation y = 0.0875 + 36.8/x2 (r = 0.759,
p < 0.01). In childhood, at the age of 6 years the con-
centration of epitestosterone is on the average higher
than the concentration of testosterone, later ratio
changes exponentially in favour of testosterone and after
puberty it remains practically constant with approxi-
mately ten times the amount of testosterone as compared
with epitestosterone.
Concentration of epitestosterone in the tissue
of hyperplastic prostate
The concentrations of epitestosterone, testosterone, di-
hydrotestosterone and androstenedione in the tissue
samples taken from 15 men between the ages of 55-82
years are given in table 3. The average tissue concentra-
tion of epitestosterone is roughly twice as high as that
of testosterone, half that of dihydrotestosterone and
close to that of androstenedione.
Tab. 2 The significance of the difference in the plasma levels of epitestosterone between various age
groups of men.
Age group (years) 0—6
0-6
7-10
11-13
14-25
26-35
36-45
46-55
56-65
7-10 11-13 14-25
NS NS NS
- + NS
NS
-
26-35 36-45 46-55
+ ++ + +
+ + ++ + +
NS ++ + +
NS NS NS
+ + NS
NS
-
56-65
+ +
+ +
+ +
NS
+ +
NS
NS
—
The significance of differences between groups was tested with the + = significance level p < 0.05;
t-test for different group variances. ++ = significance level p < 0.01; NS = not significant.
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Fig. 3 Dependence of the ratio of concentrations of epitestostero-
ne: testosterone in the plasma of boys and men on age.
full line: y = 0.0875 + 36.8/x2 (r = 0.759, p < 0.01)
dotted line: y = a + bx + ... fx5 (r = 0.659; p < 0.01)
The tissue concentration of epitestosterone correlates
positively with age (r = 0.556, p < 0.05), and even
closer is the correlation of the ratio epitestosterone: tes-
tosterone with age (r = 0.767, p < 0.01).
The tissue concentration of epitestosterone correlates lin-
early with the concentration of androstenedione (r =
0.634, p < 0.05) and dihydrotestosterone (r = 0.671, p <
0.05), but not with the concentration of testosterone.
Comparison of the concentrations of
epitestosterone and androgenic steroids in the
blood and in the prostate tissue
The ratio of epitestosterone: (testosterone + dihydrotes-
tosterone) in the plasma was 0.08, whereas in the tissue
of the hyperplastic prostate it amounted to an average
value of 0.386.
Discussion
Epitestosterone in humans is not a metabolite of testos-
terone and its excretion is not dependent on the level of
testosterone. Its biosynthesis takes place for the most
part in the testicles, where its precursor is pregnenolone
(17). The production rate of epitestosterone is only 3%
of the production rate of testosterone, but its excretion
is about 1/3 of the excretion of testosterone (18). As
mentioned in the introduction, various experimental evi-
dence has been brought so far concerning the anti-andro-
genic effect of epitestosterone in animals.
In humans we have documented the endogenous levels
of epitestosterone in males during the life span, which
has not been systematically studied. It has been found
that in the course of sexual development there appears
a marked change in the ratio of epitestosterone to
testosterone. In pre-puberty epitestosterone predomi-
nates over testosterone, while in adult men approxi-
mately a ten times greater amount of testosterone oc-
curs in the blood.
In men's hyperplastic prostate tissue epitestosterone is
present in a concentration higher than testosterone, and
approximates about half of that of dihydrotestosterone.
In prostatic tissue in comparison with the blood the
content of epitestosterone is relatively increased in con-
trast to androgens present. This is probably the result
of different pharmacokinetics and pharmacodynamics of
epitestosterone.
Provided that the binding to the receptor is comparable
(for epitestosterone K] = 29.8 nmol/1, for dihydrotes-
tosterone K! = 14.9 nmol/1 (6)), at least the same, or
better, ten times higher concentrations of antagonists
than those of agonists are necessary for evident anti-
hormonal effects. Epitestosterone circulating in the
blood in the pre-pubertal period approaches fulfillment
of these conditions, and so does the tissue epitestoster-
one in the prostate of adult men. So it can be assumed
that this steroid, long considered fully inactive, might
act as an anti-androgen and as an inhibitor of 5 -
reductase in the regulation of androgenization of the
male organism during sexual maturation and in the
regulation of androgen-dependent tissue processes, at
least as their modulator.
Tab. 3 Concentration of epitestosterone and androgens in the tissue of hyperplastic prostates
Average
SEM
Range
Median
Androstenedione
(finol/mg protein)
n = 14
71.6
8.1
22.5-132
74.6
Testosterone
(finol/mg protein)
n = 14
28.2
3.6
12.1-61.7
26.6
Epitestosterone
(finol/mg protein)
n = 15
58.4
10.4
14.0-144
47.7
Dihydrotestosterone
(finol/mg protein)
n = 15
122
7.9
53.4-165
133
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Conclusion
Epitestosterone, an endogenous steroid, long consid-
ered biologically fully inactive, has a proven anti-
androgenic effect and inhibits the biosynthesis of an-
drogens. It has been documented that its concentration
in the plasma of boys before puberty and the contents
in the tissue of the hyperplastic prostate in men
reaches values that can be assumed to counteract the
effect of the androgens present.
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